Search results for "From ACP Internist Weekly"

Results 1 - 10 of about 47 for "From ACP Internist Weekly".

Newer, older insulin formulations may offer similar glucose-lowering effects

Glargine, 300 U/mL (Glar-300), had a favorable weight profile compared with degludec, 100 U/mL (Deg-100); degludec, 200 u/mL (Deg-200); thrice-weekly degludec (Deg-3TW); glargine, ... wrote. All articles from the July 13, 2018, ACP Diabetes Monthly
July 2018

Task Force recommends screening for type 2 diabetes in overweight, obese adults

To update this recommendation, the USPSTF commissioned an evidence review that was published online April 14 by Annals of Internal Medicine and covered in the April 14 ACP Internist Weekly. ... All articles from the November 13, 2015, ACP Diabetes
November 2015

Preoperative factors may help predict long-term weight outcomes after gastric bypass, study finds

Using electronic health records from 1 health system, researchers followed 726 patients (mean age, 45.2 years; 83.1% women) for 7 to 12 years after Roux-en-Y gastric bypass ... All articles from the September 16, 2016, ACP Diabetes Monthly Newsletter.
September 2016

Analysis finds several treatments for painful diabetic neuropathy more effective than placebo

All articles from the November 14, 2014, ACP Diabetes Monthly Newsletter.
November 2014

Patients on tramadol more likely to be hospitalized for hypoglycemia

The observational case-control analysis used data from the United Kingdom Clinical Practice Research Datalink to find patients newly treated with tramadol or codeine for noncancer pain between 1998 and 2012. ... All articles from the January 9, 2015, ACP
January 2015

Study suggests less frequent retinopathy screening in low-risk patients with type 1 diabetes

Using data from the Diabetes Control and Complications Trial and its follow-up study, they assessed regularly scheduled fundus photographs obtained from about 1,400 patients from 1983 through 2012. ... All articles from the May 12, 2017, ACP Diabetes
May 2017

Exercise tips for type 1 diabetes offered by consensus statement

Severe hypoglycemia (blood glucose level 2.8 mmol/L [50 mg/dL]) or a hypoglycemic event requiring assistance from another individual within the previous 24 hours is a contraindication to exercise, ... All articles from the February 10, 2017, ACP Diabetes
February 2017

From ACP Internist Weekly

A pen injector was used for the once-weekly injections, and a vial and syringe were used for the once-daily injections. ... All articles from the October 9, 2020, ACP Diabetes Monthly Newsletter.
October 2020

Kidney failure, CV events lower with canagliflozin than placebo, industry study finds

stage kidney disease, doubling of creatinine, or death from renal causes) (HR, 0.66; 95% CI, 0.53 to 0.81; P<0.001) with the drug. ... All articles from the May 10, 2019, ACP Diabetes Monthly Newsletter.
May 2019

Diabetes Collaborative Registry seeks primary care participants

ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry and interdisciplinary collaboration designed to assess and improve the quality ... ACP has partnered
August 2015

Result Page: Prev   1   2   3   4   5   Next